SCHEMBL1768652

SCHEMBL1768652

CCCCCCCCCCCCCCC[C](O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.60
PPARG P37231 7/20 0.60
PPARD Q03181 7/20 0.60
PPARA Q07869 7/20 0.60
HDAC11 Q96DB2 5/20 0.60
TSHR P16473 5/20 0.60
PTPN1 P18031 3/20 0.60
ALDH1A1 P00352 2/20 0.60
TLR2 O60603 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
FABP4 P15090 2/20 0.60
KMT2A Q03164 2/20 0.60
SLC22A6 Q4U2R8 1/20 0.60
SLC22A8 Q8TCC7 1/20 0.60
MEN1 O00255 1/20 0.60
ESR1 P03372 1/20 0.60
ALOX15 P16050 1/20 0.60
PDE4A P27815 1/20 0.60
PDE3A Q14432 1/20 0.60
HSD17B10 Q99714 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633330 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6507588 1.00
SCHEMBL2524053 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3422866 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL2969247 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7461021 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL18035657 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1542858 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1685840 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL27497814 1.00 GPR84 (0.60) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512606-A1 NOVEL COSMETIC AND/OR NUTRACEUTICAL OR DERMATOLOGICAL USE OF A YEAST EXTRACT BASF Beauty Care Solutions France SAS (FR) 2019-07-24 EP disclosed
US-9060943-B2 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent SYMRISE AG (DE) 2015-06-23 US disclosed
CN-103068884-B Photosensitive silicone resin composition ASAHI KASEI E MATERIALS CORP 2015-06-17 CN disclosed
CN-103068884-A Photosensitive silicone resin composition ASAHI KASEI E MATERIALS CORP 2013-04-24 CN disclosed
US-8323628-B2 Long wear cosmetic composition L'OREAL (FR) 2012-12-04 US disclosed
US-20120121737-A1 COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT SYMRISE AG (DE) 2012-05-17 US disclosed
CN-102317822-A Polarizing plate having cured silicone coating film, and liquid crystal display device produced using same NIPPON STEEL CHEMICAL CO 2012-01-11 CN disclosed
US-20110123472-A1 LONG WEAR COSMETIC COMPOSITION L'OREAL S.A. 2011-05-26 US disclosed
US-7855310-B2 AH receptor antagonists SYMRISE GMBH & CO. KG (DE) 2010-12-21 US disclosed
CN-100545184-C The organosilicon resin composition and the formed body thereof that contain silicon-dioxide NIPPON STEEL CHEMICAL CO (JP) 2009-09-30 CN disclosed
US-20090208432-A1 AH Receptor Antagonists SYMRISE GMBH & CO., KG (DE) 2009-08-20 US disclosed
US-20090208433-A1 aryl hydrocarbon receptor (Ah receptor; AhR) antagonists such as 2-benzylidene-5,6-dimethoxy-3H-inden-1-one, used for preventing a translocation of an AhR into a cell nucleus, ultraviolet radiation-induced gene expression or skin damage; cosmetics; sunscreen agents; aldol condensation SYMRISE GMBH & CO., KG (DE) 2009-08-20 US disclosed
CN-101027330-A Silica-containing silicone resin composition and its molded product NIPPON STEEL CHEMICAL CO (JP) 2007-08-29 CN disclosed
US-20070166257-A1 Long wear cosmetic composition L'OREAL S.A. (FR) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090208432-A1 AH Receptor Antagonists AHR, ARNT, HCAR1 GPR84 42/4885PPARG 304/4885PPARD 362/4885
US-20090208433-A1 aryl hydrocarbon receptor (Ah receptor; AhR) antagonists such as 2-benzylidene-5,6-dimethoxy-3H-inden-1-one, used for preventing a translocation of an AhR into a cell nucleus, ultraviolet radiation-induced gene expression or skin damage; cosmetics; sunscreen agents; aldol condensation AHR, ARNT, AIPL1 GPR84 891/4885PPARG 58/4885PPARD 138/4885
US-20120121737-A1 COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT TERT, CUTA, TRPA1 GPR84 2110/4885PPARG 1511/4885PPARD 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.